Weight Gain and its Correlates among Breast Cancer Survivors  by Kim, Soo Hyun et al.
lable at ScienceDirect
Asian Nursing Research 7 (2013) 161e167Contents lists avaiAsian Nursing Research
journal homepage: www.asian-nursingresearch.comResearch ArticleWeight Gain and its Correlates among Breast Cancer Survivors
Soo Hyun Kim, RN, PhD, OCN,1,* Young Up Cho, MD, PhD, 2 Sei Joong Kim, MD, PhD 2
1Department of Nursing at the Inha University, Incheon, South Korea
2Department of Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, South Koreaa r t i c l e i n f o
Article history:
Received 18 January 2013
Received in revised form
23 May 2013
Accepted 12 August 2013
Keywords:
body weight changes
breast neoplasms
Korea* Correspondence to: Soo Hyun Kim, RN, PhD, OCN,
University, 253 Yonghyun-dong, Nam-gu, Incheon 410
E-mail address: soohyun@inha.ac.kr
1976-1317/$ e see front matter Copyright  2013, Ko
http://dx.doi.org/10.1016/j.anr.2013.09.002s u m m a r y
Purpose: Weight gain after diagnosis of breast cancer is a profound issue that may negatively impact
cancer prognosis. However, most existing research on weight change has been conducted in Western
countries. In addition, several factors related to weight gain have been reported; however, the evidence is
inconsistent. The purpose of this study was to examine weight gain and its correlates among Korean
breast cancer survivors.
Methods: A total of 132 female breast cancer survivors were recruited from one university hospital in
South Korea. Participants completed anthropometric measurements (i.e., body weight, height) and a self-
reported questionnaire, including the International Physical Activity Questionnaire Short Form and Mini
Dietary Assessment.
Results: The meanweight change was 0.09 kg (SD ¼ 4.28). Only 27 women (19.7%) gained more than 5%
of their weight at diagnosis, 59.1% maintained weight, and 21.2% lost weight. In multivariate logistic
regression analysis, signiﬁcant correlates of weight gain were younger age, obesity at diagnosis, duration
of more than 36 months since diagnosis, and low diet quality.
Conclusion: Younger women, women who were obese at diagnosis, women with more than 36 months
since diagnosis, or women who showed lower diet quality should be considered at high-risk for weight
gain. Findings from our study suggest that optimal weight management strategies should be developed
using ethnically- or culturally-appropriate approaches.
Copyright  2013, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Breast cancer is the second most commonly diagnosed cancer
among Korean women (National Cancer Information Center, 2012).
Although the incidence of breast cancer in Korea is lower than that
in Western countries, it is rapidly increasing, with an annual
growth rate of 6.3% (National Cancer Control Institute). Due to early
detection and advanced medical treatment, the 5-year survival rate
in Korean breast cancer patients has increased from 77.9% in 1993e
1995 to 90.6% in 2005e2009 (National Cancer Control Institute),
which is comparable to that in the United States and Canada. As the
number of breast cancer survivors increased, cancer survivorship
issues among this population have become more important.
Weight gain is a common and persistent problem for many
breast cancer survivors (Vance, Mourtzakis, McCargar, & Hanning,
2011). As many as 50e96% of women diagnosed with breast can-
cer experience signiﬁcant weight gain during treatment (Rock &
Demark-Wahnefried, 2002). Weight gain usually ranges fromDepartment of Nursing, Inha
-742, South Korea.
rean Society of Nursing Science. P1.0 kg to 6.0 kg during the ﬁrst year after diagnosis (Demark-
Wahnefried et al., 2001; Goodwin, 2001; Irwin et al., 2005;
Makari-Judson, Judson, & Mertens, 2007). Several studies have re-
ported that weight gain after breast cancer diagnosis may have a
negative impact on quality of life, increase the risk for recurrence,
and shorten survival time (Chlebowski, Aiello, & McTiernan, 2002;
Demark-Wahnefried, Rimer, & Winer, 1997; Kroenke, Chen, Rosner,
& Holmes, 2005).
Weight gain is more common in women receiving adjuvant
chemotherapy, particularly for women undergoing treatments that
require a longer duration, and it appears to be especially pro-
nounced in premenopausal women (Caan et al., 2008; McInnes &
Knobf, 2001; Vance et al., 2011). Other factors suggested to inﬂu-
ence weight gain after cancer diagnosis include age (Caan et al.,
2008; Chen et al., 2011; Gu et al., 2010), advanced disease stage
(Caan et al., 2008; Gu et al.; Irwin et al., 2005; Saquib et al., 2007),
decreased physical activity (Demark-Wahnefried et al., 1997; Irwin
et al.; Rock et al., 1999) and increased energy intake (Chen et al.;
Demark-Wahnefried et al., 1997; Rock et al., 1999). However, the
evidence is limited and inconsistent. For example, Goodwin et al.
(1999) reported that adjuvant chemotherapy was a strong and in-
dependent clinical factor of weight gain. The Health, Eating,ublished by Elsevier. All rights reserved.
Figure 1. Conceptual framework for the study. Note. ER ¼ estrogen receptor; PR ¼ progesterone receptor; CT ¼ chemotherapy; RT ¼ radiation therapy; SERM ¼ selective estrogen
receptor modulator; AI ¼ aromatase inhibitor.
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chemotherapy with greater weight gain (Irwin et al.). However, a
Korean study found that women with early stage breast cancer did
not gain weight after adjuvant chemotherapy (Han et al., 2009),
which was similar to the results of the study by Campbell, Lane,
Martin, Gelmon, and McKenzie (2007) in Canada. In addition,
premenopausal status showed a signiﬁcant associationwith weight
gain (Caan et al., 2008; Chen et al.; Heideman, Russell, Gundy,
Rookus, & Voskuil, 2009), contradicting ﬁndings from the Health,
Eating, Activity, and Lifestyle Study (Irwin et al.) and the Korean
study (Han et al.).
Most existing research onweight change has been conducted in
Western countries, where the prevalence of obesity is relatively
high (Demark-Wahnefried et al., 2001; Goodwin et al., 1999; Irwin
et al., 2005; McInnes & Knobf, 2001; Rock et al., 1999). The preva-
lence of obesity [body mass index (BMI)  30 kg/m2] and of over-
weight and obesity combined (BMI  25 kg/m2) in the US were
35.7% and 68.8% (Flegal, Carroll, Ogden, & Curtin, 2010), respec-
tively. On the other hand, those in Korea were 3.9% and 30.9%,
respectively (Oh, 2011). Because there are differences in the
epidemiology of obesity and breast cancer between Asian and
Western regions, theremay also be ethnic differences in the pattern
of weight gain after initiation of breast cancer treatment (Han et al.,
2009). However, few studies have investigated weight change and
related factors among Asian women after breast cancer diagnosis.
Han and colleagues conducted a retrospective study of weight
change after breast cancer diagnosis among the Korean population.
They found no weight gain after adjuvant therapy for breast cancer,
which is inconsistent with previous ﬁndings from Western coun-
tries (Chlebowski et al., 2002; Demark-Wahnefried et al., 1997;
Goodwin et al., 1999; McInnes & Knobf). However, in a population-
based cohort study among Chinese women, Gu et al. (2010) re-
ported that weight gain was common over the ﬁrst 3 years after
breast cancer diagnosis. Thus, patterns of weight change among
Asian breast cancer survivors remain controversial. In addition,
there were differences in the correlates of weight change. For
example, in the study by Han et al., BMI at diagnosis and hormone
therapy showed signiﬁcant correlations with weight change, while
in the study by Gu et al., age, stage and comorbidity were signiﬁcantfactors showing an associationwith weight gain. These two studies
only evaluated correlates in terms of sociodemographic and clinical
factors while they did not include lifestyle factors related to weight
gain.
Therefore, the aims of the current study were to examine the
prevalence of weight gain and its correlates among Korean breast
cancer survivors. For comprehensive identiﬁcation of correlates
of weight gain, we developed a conceptual framework that
included sociodemographic, clinical, and lifestyle factors for
explaining weight gain (Figure 1). We expect that our ﬁndings will
help identify women who are most at risk and will inform the
development of culturally-appropriate weight management in-
terventions aimed at promoting overall health and long-term
survivorship.
Methods
Study design
This study used a retrospective and cross-sectional descriptive
study design.
Setting and sample
Participants were breast cancer survivors from the outpatient
department of the breast cancer center at a university hospital in
South Korea. Participants were included in this study if they (a)
were women who had histologically conﬁrmed stage IeIII breast
cancer, (b) had received at least one treatment for breast cancer,
and (c) had completed their primary treatment, except hormone
therapy. Participants were excluded if they (a) had distant metas-
tasis, (b) had a previous or concurrent history of other cancer(s), or
(c) did not have a baseline body weight.
To verify the statistical power of our sample, we used the
G*Power 3.1 software (Faul, Erdfelder, Buchner, & Lang, 2009). The
sample size required in logistic regression method was 132 with
the following parameters: odds ratio (OR) ¼ 1.69, Cronbach’s
a ¼ .05, power ¼ 80%, rate of outcome ¼ 44% based on previous
research (Saquib et al., 2007). Of the 185 breast cancer survivors
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lection criteria and were invited to participate in this study. A total
of 132 women participated voluntarily in the study, giving a
response rate of 82.5%.
Ethical consideration
At the meeting with each participant, the researcher explained
the purpose and the procedures of the study and obtained written
informed consent before the data collection procedure. Participants
were informed that they were not obliged to participate in the
study and could withdraw any time they wished. The participating
institutional review board reviewed and approved the protocol and
consent form for the study.
Measurements
Anthropometric measurements
Body weight and height. A trained research nurse took anthro-
pometric measurements twice according to a standard protocol.
Weight was measured to the nearest 0.1 kg using a digital weight
scale (Seca model 707; Vogel & Halke GmbH & Co., Hamburg,
Germany). Participants were weighed while wearing light clothes
and no shoes; participants’ height was also measured without
shoes. Information on body weight and height at diagnosis was
extracted from medical records.
BMI. BMI was calculated by dividing weight (kg) by height (m)
squared. Overweight and obesity were categorized according to the
World Health Organization (WHO) criteria for Asians (WHO &
International Association for the Study of Obesity, International
Obesity Task Force, 2000). In 2000, the Regional Ofﬁce for the
Western Paciﬁc Region ofWHO, the International Association for the
Study of Obesity, and the International Obesity Task Force proposed a
separate classiﬁcation of obesity for Asians, i.e., a BMI of 25 kg/m2.
Weight change. Relative percent weight changes between current
weight and weight at diagnosis were calculated {[current weight
(kg)weight at diagnosis (kg)]/weight at diagnosis (kg)}  100. The
participants were then categorized into three groups: weight loss
group (loss  5%), weight stable group (within 5%), and weight gain
group (gain  5%). These change categories were chosen because
they were commonly used in previous studies (Caan et al., 2008; Gu
et al., 2010; Han et al., 2009; Saquib et al., 2007).
Lifestyle variables
Physical activity. Physical activity was assessed using the Inter-
national Physical Activity Questionnaire Short Form (IPAQ-SF)
(Craig et al., 2003). This is a 9-item scale that assesses the number
of minutes spent in vigorous and moderate intensity activity and
walking during the last 7 days. Participants were required to deﬁne
how many days and how many minutes they spent at a speciﬁc
activity category. For all categories, the amount of metabolic
equivalent task (MET)-minutes was calculated by multiplying the
number of minutes by 8 (vigorous), 4 (moderate), 3.3 (walking), or
1.3 (sitting). Based on these calculations, three classiﬁcation groups
were arbitrarily deﬁned: low (< 3 MET-hour/week), moderate (3e
21.9 MET-hour/week), and high ( 22 MET-hour/week). A reli-
ability and validity study previously conducted in 14 centers in 12
countries reported acceptable measurement properties of IPAQ-SF
for monitoring population-level PA among 18e65-year-old adults
in diverse settings (Craig et al.).
Exercise habits. Because the IPAQ-SF provides the overall level of
physical activity, we also collected information about participants’
exercise habits in the past year (type of exercise, frequency, time).
However, this was limited to examining speciﬁc exercise behaviors.
Current public health exercise guidelines recommend exercise ofmoderate intensity for more than 150 minutes/week or of vigorous
intensity for more than 75 minutes/week (Kushi et al., 2006;
Schmitz et al., 2010). Thus, we calculated total minutes per week
by combining the measures of moderate and vigorous exercise.
Diet quality. We assessed diet quality using the Mini Dietary
Assessment Index for Koreans (MDA) (Kim, Cho, & Lee, 2003) This
was developed for assessment of the quality of the Korean diet and
for screening nutritional status. It includes a total of 10 questions on
meal regularity, diet diversity, intake frequency for each food group
and snacks, and preference for salty taste. Answers to most ques-
tions receive 5, 3, and 1 points for always true, sometimes true, and
not necessarily true, respectively. However, questions on the fre-
quency of consuming snacks and high fat food and on preference
for salty taste receive 1, 3, and 5 points for answers of always true,
sometimes true, and not necessarily true, respectively. The total
possible score is 50. Higher MDA scores reﬂect a higher quality diet.
MDA shows high reliability and validity (Kim et al.) and has been
used in various settings in Korea.
Smoking and alcohol consumption. These two items were based
on items in the Korean National Health and Nutrition Examination
Survey. Smoking behavior was categorized as “never smoker,” “past
smoker,” and “current smoker”. Alcohol consumption was assessed
in terms of type of alcohol and frequency of drinking.
Procedure
A research nurse identiﬁed potential participants, conducted in-
person interviews and explained the purpose of the study. Each
participant received an informed consent form and was adminis-
tered a questionnaire including questions on sociodemographic
(i.e., age, education level, job, monthly income, & menopausal
status) and lifestyle factors (i.e., physical activity, exercise habit,
diet quality, smoking behavior, & alcohol consumption). After
completion of the questionnaire, the weight and height of each
participant were measured. Medical charts were reviewed to
collect information on clinical factors (i.e., time since diagnosis,
stage, type of surgery, hormone status, history of chemotherapy or
radiation therapy, use of antihormone agents, comorbidity, and
obesity at diagnosis) and weight/height at diagnosis.
Data analysis
Descriptive statistics were performed for all sociodemographic,
clinical, lifestyle characteristics, and anthropometric data. To test
our hypotheses, we reclassiﬁed the outcome variable of weight
change from three groups to two groups (i.e., weight gain group vs.
weight stable/weight loss group). For multivariate analyses, the
associations of individual sociodemographic, clinical, and lifestyle
characteristics and weight gain were examined separately using
simple logistic regression analysis. Variables that were signiﬁcant
or nearly signiﬁcant factors showing association with weight gain
in univariate tests (i.e., simple logistic regression analysis; p < .10)
were considered for use in the ﬁnal model of multivariate logistic
regression analysis (Goodwin et al., 1999). Multicollinearity was
examined using the variance inﬂation factor. A two-sided p < .05
indicated statistical signiﬁcance. We performed data analysis using
SPSS 19.0 version (SPSS Inc., Chicago, IL, USA).
Results
Sociodemographic, clinical, and lifestyle characteristics of
participants
The mean age of the women was 51.48 years (SD ¼ 7.58). Most
were married andmore than half of the participants had more than
Table 1 Sociodemographic, Clinical, and Lifestyle Characteristics of Study Participants
(N ¼ 132)
Characteristic n (%) M  SD
Age (yr) 51.48  7.58
<50 55 (41.7)
50 77 (58.3)
Marital status
Married 124 (93.9)
Divorced/widowed/single 8 (6.1)
Education level
<High school 47 (35.6)
High school 85 (64.4)
Job
Yes 49 (37.1)
No 83 (62.9)
Monthly income (US$)
<2,000 43 (32.6)
2,000 89 (67.4)
Menopausal status at diagnosis
Premenopausal 91 (68.9)
Postmenopausal 41 (31.1)
Time since diagnosis (month) 34.11  26.07
<12 21 (15.9)
12e35 58 (43.9)
36 53 (40.2)
Stage
0eI 56 (42.4)
II 56 (42.4)
III 20 (15.2)
Estrogen receptor status
Yes 102 (77.3)
No 28 (21.2)
Missing 2 (1.5)
Progesterone receptor status
Yes 93 (70.5)
No 37 (28.0)
Missing 2 (1.5)
Type of surgery
Mastectomy 71 (53.8)
Breast conserving surgery 61 (46.2)
Received chemotherapy
Yes 106 (80.3)
No 26 (19.7)
Type of chemotherapy regimen (n ¼ 106)
AC 51 (48.1)
TAC 37 (34.9)
CMF 13 (12.3)
Others 5 (4.7)
Received radiation therapy
Yes 78 (59.1)
No 54 (40.9)
Current or past use of SERM
Yes 87 (65.9)
No 45 (34.1)
Current or past use of AI
Yes 26 (19.7)
No 106 (80.3)
Comorbidity
Yes 43 (32.6)
No 89 (67.4)
Physical activity
IPAQ classiﬁcation (n ¼ 118)
Low 29 (24.6)
Moderate 59 (50.0)
High 30 (25.4)
Meet criteria of public recommendationa
Yes 81 (61.4)
No 51 (38.6)
Diet quality
MDA total score 40.82  5.28
Smoking
Never 119 (90.1)
Past 8 (6.1)
Current 5 (3.8)
Alcohol consumption (frequency)
Never 98 (74.3)
1/month 13 (9.8)
Table 1 (continued )
Characteristic n (%) M  SD
2e4/month 14 (10.6)
2e3/week 6 (4.5)
4/week 1 (0.8)
Note. AC ¼ doxorubicin þ cyclophosphamide; TAC ¼ docetaxel þ doxorubicin þ
cyclophosphamide; CMF ¼ cyclophosphamide þ methotrexate þ ﬂuorouracil-1;
SERM ¼ selective estrogen receptor modulator; AI ¼ aromatase inhibitor;
IPAQ ¼ International Physical Activity Questionnaire; MDA ¼ Mini Dietary
Assessment.
a Criteria for public recommendation of exercise was deﬁned as exercise more
than 150 minutes/week with moderate intensity or 75 minutes/week with vigorous
intensity.
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premenopausal at diagnosis. The mean duration of time from
diagnosis to study entry was 2.84 years (SD ¼ 2.17). The majority
received chemotherapy (80.3%) and 59.1% of participants received
radiation therapy. According to the IPAQ-SF classiﬁcation, 24.6% of
the participants had low physical activity, 50.0% had moderate
physical activity, and 25.4% had high physical activity. Eighty-one
women (61.4%) met the criteria of the public recommendation for
physical activity (i.e., 150 minutes or more per week). The mean
total MDA score was 40.82 (SD ¼ 5.28). The majority had no
experience with smoking; only 13 women (9.9%) reported being
past or current smokers. Most women (74.3%) reported not drink-
ing any alcohol (Table 1).
Weight change
The mean weight change was 0.09 kg (SD ¼ 4.28). Of the 132
participants, more than half (59.1%) maintained their weight, 19.7%
gained more than 5% of their weight at baseline, and 21.2% lost
weight. The proportion of overweight or obese participants
decreased from diagnosis to study entry. At the time of breast
cancer diagnosis, 64.4% of women were overweight or obese
(BMI  23 kg/m2) and 62.2% were overweight or obese at study
entry (Table 2).
Correlates of weight gain
The univariate analyses of associations betweenweight gain and
sociodemographic, clinical, and lifestyle factors are presented in
Table 3. Variables associated in the univariate analysis at a level
where p < .10 were considered for inclusion in the multivariate
model. In univariate analyses, younger age (i.e., age < 50 years;Table 2 Descriptive Statistics of Weight Change (N ¼ 132)
Characteristic n (%) M  SD
At diagnosis
Weight (kg) 59.69  9.20
Overweight or obesity (BMI  23.0 kg/m2) 85 (64.4)
At study entry
Weight (kg) 59.60  9.34
Overweight or obesity (BMI  23.0 kg/m2) 82 (62.2)
Weight change (kg) 0.09  4.28
Weight change classiﬁcationa
Weight loss group 28 (21.2)
Weight stable group 78 (59.1)
Weight gain group 26 (19.7)
Note. BMI ¼ body mass index.
a Weight loss group ¼ {[current weight (kg)weight at diagnosis (kg)]/weight at
diagnosis (kg)}  100  5%; weight stable group ¼ 5% < {[current weight (kg)
weight at diagnosis (kg)]/weight at diagnosis (kg)}  100 < 5%; weight gain
group ¼ {[current weight (kg)weight at diagnosis (kg)]/weight at diagnosis
(kg)}  100  5%.
Table 3 Univariate and Multivariate Analyses of Correlates of Weight Gain (N ¼ 132)
Variables Univariate analysis Multivariate analysis
OR 95% CI p aOR 95% CI p
Age < 50 years (ref.  50 years) 2.75 1.14e6.65 .025 3.75 1.28e11.02 .016
Married (ref. unmarried or widowed or divorced) 2.64 0.59e11.82 .206
<High school graduation (ref.  high school graduation) 1.17 0.48e2.83 .735
Having a job (ref. no job) 2.89 1.20e6.95 .018 2.30 0.83e6.38 .110
Monthly income < US$2,000 (ref.  US$2,000) 1.12 0.45e2.77 .804
Premenopausal at diagnosis (ref. postmenopausal at diagnosis) 0.98 0.39e2.49 .971
Time since diagnosis  36 months (ref. time since diagnosis < 36 months) 3.67 0.11e0.67 .005 4.71 1.58e14.06 .005
Stage  IIb (ref. stage ¼ I or IIa) 1.12 0.43e2.94 .815
Positive ER (ref. negative ER) 3.79 0.84e17.16 .084
Positive PR (ref. negative PR) 1.75 0.61e5.08 .301
Mastectomy (ref. breast conserving surgery) 1.22 0.51e2.90 .656
Received chemotherapy (ref. not received chemotherapy) 1.44 0.45e4.61 .539
Received radiation therapy (ref. no radiation therapy) 0.93 0.39e2.22 .871
SERM use (ref. no SERM use) 2.55 0.89e7.28 .082 2.26 0.68e7.48 .182
AI use (ref. no AI use) 0.69 0.22e2.22 .539
Having a comorbid condition (ref. no comorbid condition) 1.11 0.44e2.80 .826
Obesity at diagnosis (ref. BMI < 25.0 kg/m2) 3.70 1.52e9.03 .040 3.45 1.24e9.63 .018
Low physical activity (ref. IPAQ ¼ high or moderate group) 1.81 0.56e5.82 .318
Unmet public guideline of exercise (ref. weekly minutes of moderate
intensity exercise  150 min)
1.21 0.51e2.89 .668
Low diet quality (ref. MDA score  40.8)a 2.17 0.90e5.22 .084 2.12 1.15e6.54 .042
Current or past smokers (ref. never smokers) 0.15 0.04e1.28 .231
Drinking  2 times/week (ref. < 2 times/week) 0.31 0.07e1.48 .142
Note. OR¼ odds ratio; aOR¼ adjusted odds ratio; ref. ¼ reference group; ER¼ estrogen receptor; PR¼ progesterone receptor; SERM¼ selective estrogen receptor modulator;
AI ¼ aromatase inhibitor; BMI ¼ body mass index; IPAQ ¼ International Physical Activity Questionnaire; MDA ¼ Mini Dietary Assessment.
a This categorization was based on the mean score of MDA in our sample.
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more than 36 months since diagnosis (OR ¼ 3.67, p ¼ .005), es-
trogen receptor (ER) positive (OR ¼ 3.79, p ¼ .084), use of selective
estrogen receptor modulators (SERM; OR ¼ 2.55, p ¼ .082), obesity
at diagnosis (OR ¼ 3.70, p ¼ .040), and low diet quality (i.e., below
the mean score of MDA; OR ¼ 2.17, p ¼ .084) were associated with
weight gain.
Before entering the seven factors into a multivariate model, we
checked for multicollinearity. Although there was no problem of
multicollinearity using the variance inﬂation factor (range: 1.004e
1.839) among the seven potential correlates of weight gain, we
detected a potential clinical multicollinearity problem between ER
status and SERM use. Among women who are ER positive, most
should use SERM. Therefore, we did not include a variable of ER
status in the ﬁnal model. Thus, six factors derived from univariate
analysis were entered into the multivariate model simultaneously.
The overall model exhibited a good ﬁt with the data (c2 ¼ 35.181,
p < .001, Nagelkerke R2 ¼ .436). In multivariate logistic regression
analysis, four variables were found to be signiﬁcant correlates of
weight gain: younger age (OR ¼ 3.75, p ¼ .016), duration of more
than 36 months since diagnosis (OR ¼ 4.71, p ¼ .005), obesity at
diagnosis (OR ¼ 3.45, p ¼ .018), and lower diet quality (OR ¼ 2.12,
p ¼ .042) (Table 3).
Discussion
Weight gain is a common phenomenon among breast cancer
survivors (Chen et al., 2011; Chlebowski et al., 2002; Demark-
Wahnefried et al., 1997; Goodwin et al., 1999; Gu et al., 2010;
McInnes & Knobf, 2001; Vance et al., 2011). However, the ﬁndings
of the current study do not support the existing evidence indicating
that women tend to gain weight after breast cancer therapy. In
contrast with the majority of studies conducted in the West, we
observed no weight gain in our Korean breast cancer survivors. Of
particular interest, factors showing an associationwith weight gain
were somewhat different than those reported in previous studies.In the current study, the mean weight change was 0.09 kg.
Only 19.7% of the participants reportedweight gain of more than 5%
of their weight at diagnosis, which was much lower than in pre-
vious data from the West (range: 38.9%e47.8%; Caan et al., 2006,
2008; Saquib et al., 2007) or from Asian countries (Gu et al.,
2010; Yaw et al., 2011). Han et al. (2009) observed no weight gain
after adjuvant therapy among Korean breast cancer survivors. In
that study (Han et al.), the mean weight changes were 0.3 kg at 1
year and 0.4 kg at 2 years after cancer treatment, and only 10% of
women gained more than 5% of baseline body weight at 1 year.
These results were in line with our ﬁndings. However, data on
weight change in Asian populations are limited; therefore, more
research in this area is needed.
Lack of weight gain after treatment among Korean breast cancer
survivors may be a unique phenomenon. This discordant ﬁnding
may be related to characteristics of breast cancer occurrence in
Korea. Compared with their counterparts from Western countries,
Korean patients characteristically develop breast cancers at a
younger age. The median age of Korean breast cancer patients is in
the late 40s, which is more than 10 years younger than that of
patients from North America or Europe. In addition, approximately
half of Korean breast cancer patients are under the age of 50 (Jung
et al., 2011). Second, dietary habits of Korean people may be
partially responsible for the lack of weight gain. Most Korean pa-
tients with breast cancer believe that eating meat could increase
the risk of recurrence and therefore tend to avoid eating meat (Min
et al., 2008). Our data on diet quality supported this speculation;
the score for intake of meat, ﬁsh, and eggs was the second lowest
item. This change in diet could inﬂuence the pattern of weight
change in our participants. Third, hospital-based education could
contribute to the lack of weight gain observed in our study. The
hospital that participated in this study runs a group education class
for patients who are admitted for surgery. Weight management is
one of the main topics in this class. Most patients come to under-
stand that weight gain may negatively impact their prognosis.
Finally, another possible explanation may be related to
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ipants received anthracycline-based chemotherapy, administered
over a relatively short period of time. Previous research has indi-
cated that weight gain was higher among women who underwent
treatment with chemotherapy over longer periods of time
(Demark-Wahnefried, Winer, & Rimer, 1993).
We examined the correlates of weight gain, including socio-
demographic, clinical, and lifestyle factors. Among sociodemo-
graphic characteristics, age was a signiﬁcant factor showing an
association with weight gain. In our study, we found that younger
women were more likely to gain weight than older women were,
consistent with earlier reports (Demark-Wahnefried et al., 2001;
Goodwin, 2001; Irwin et al., 2005; Rock et al., 1999). Previous
studies have reported a signiﬁcant correlation of premenopausal
status at diagnosis with greater weight gain (Campbell et al., 2007;
Demark-Wahnefried et al., 1993, 1997; Huntington, 1985; McInnes
& Knobf, 2001). However, not all studies have reported such a
ﬁnding (Han et al., 2009; Irwin et al.; Rock et al., 1999). In this study,
we did not ﬁnd this association. According to Heideman et al.
(2009), weight gain was largely limited to premenopausal
women, who gained an average of 3.9 kg. Thus, this relationship
may not be apparent in our study, which revealed no weight gain.
The association between menopausal status and weight change
remains controversial and further research is needed.
Among clinical factors, two factors showed signiﬁcant correla-
tion with weight gain. In our study, time since diagnosis showed a
signiﬁcant association with weight gain. Womenwho had received
their diagnosis more than 36 months ago were more likely to gain
weight than women who had not; this ﬁnding was similar to that
reported by Caan et al. (2006). Second, obesity status at diagnosis
showed a signiﬁcant association with weight gain. This result was
contradictory to ﬁndings from previous studies (Gu et al., 2010;
Yaw et al., 2010) In our study, women who were obese at diag-
nosis were more likely to gain weight than women who were not,
whereas in two previous studies, women who were obese at
diagnosis had lower risk of weight gain (Gu et al.; Yaw et al., 2010).
Differences in study design, characteristics of the study pop-
ulations, or categorization of BMImay account for the discrepancies
between our study and previous studies (Gu et al.; Yaw et al., 2010).
A relationship between lifestyle factors and weight gain in
breast cancer survivors has been suggested (Chen et al., 2011;
Demark-Wahnefried et al., 2001; Goodwin, 2001; Irwin et al.,
2005; Rock et al., 1999; Yaw et al., 2011). However, this relationship
has not been fully evaluated and evidence has been inconsistent.
Factors previously reported as signiﬁcant correlates of weight gain
included low levels of physical activity (Rock et al., 1999), higher
levels of energy intake (Chen et al.; Rock et al., 1999), and smoking
(Chen et al.). In our study, diet quality showed an independent
association with weight gain. This is a new ﬁnding. Previous re-
searchers have only evaluated intake of speciﬁc nutrients or energy
intake. However, the ﬁndings of our study suggest that assessment
of diet quality may also be important for weight management ed-
ucation for women with breast cancer after therapy.
This study has several limitations. Our sample was recruited
from only one university hospital and the small sample size of this
study may not be representative of the population of women with
breast cancer in Korea. This study was a retrospective study with a
cross-sectional study design, which causes difﬁculty in identiﬁca-
tion of cause-and-effect relationships with regard to weight gain. A
longitudinal study design is most appropriate for identiﬁcation of
such relationships. On the other hand, our study has several
strengths. First, we collected detailed information on sociodemo-
graphic, clinical, and lifestyle factors, which allowed a compre-
hensive evaluation of correlates of weight gain. Second, trained
nurses performed anthropometric measurements during studyrecruitment, and medical charts were reviewed for collection of
information onweight at cancer diagnosis. Third, because relatively
little is known about weight gain among Asian breast cancer sur-
vivors, this study adds to our knowledge.
Conclusions
In conclusion, the results of this study indicate that weight gain
is not common among Korean breast cancer survivors. In this study,
younger age, obesity at diagnosis, duration of more than 36months
since diagnosis, and lower diet quality showed signiﬁcant correla-
tion with weight gain. These ﬁndings differ from those of previous
studies conducted in Western countries; therefore, the results of
the current study suggest that nurses should provide ethnically- or
culturally-appropriate weight management intervention. Among
the Korean population of women with breast cancer, women who
were obese at diagnosis and women who received their diagnosis
more than 36 month ago should receive special attention. Early
identiﬁcation of these women and close monitoring are important,
so that timely and appropriate counseling may be offered.
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